Zoekresultaten - 9 results

Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.

factors for HPV infection that collected samples from anogenital sites and used PCR or hybrid capture 2 techniques for HPV DNA detection. Exclusion criteria were studies conducted among populations at ...

The impact of the COVID-19 pandemic on the presentation rate and severity of diabetic foot ulcers in Belgium

Between January 1st and September 30th, patient and ulcer characteristics were recorded for 887 consecutive patients with DFU s of Wagner 2 or higher. Based on the date of presentation in the DFC, patients ...

Tackling cervical cancer in Europe amidst the COVID-19 pandemic.

low in countries with the highest incidence and screening performance is heterogeneous among European countries. Cytological screening followed by treatment of screen-detected cervical lesions has ...

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

participation trials were included. hrHPV assays based on polymerase chain reaction were as sensitive on self samples as on clinician samples to detect CIN2 + or CIN3 + (pooled ratio 0.99, 95% confidence interval ...

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.

Keywords: Confidence Intervals DNA, Viral Early Detection of Cancer Female Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening Papillomaviridae Papillomavirus Infections Practice ...

Activity-Based Detection and Bioanalytical Confirmation of a Fatal Carfentanil Intoxication.

a fatality in Norway. Blood, urine and vitreous, obtained during autopsy, were screened with a newly developed opioid activity reporter assay able to detect compounds based on their μ-opioid receptor activity ...

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Detection of Cancer Female Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening middle aged Papillomaviridae Papillomavirus Infections Reagent Kits, Diagnostic Uterine Cervical Neoplasms ...

Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.

+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-risk human papillomavirus (HPV) types. LMNX is additionally provided ...

Chapter 10: HPV testing on cervical cancer specimens: which assay can be used in cervical cancer screening.

tests (validated in population-based randomised trials: Hybrid Capture 2 HPV DNA Test; GP5 +/6+ PCR- EIA. hrHPV DNA tests validated consistently in multiple studies against standard comparator tests: ...

QR code

QR code for this page URL